B. Riley Securities analyst Kalpit Patel downgrades IN8bio (NASDAQ:INAB) from Buy to Neutral and lowers the price target from $9 to $3.
WidePoint’s Subsidiary IT Authorities Awarded New Contract To Provide Managed IT Services; 3-Year Contract Initially Valued At $216,000 From A Mobile Healthcare Provider
WidePoint Corporation (NYSE:WYY), the innovative technology Managed Solution Provider (MSP) specializing in Identity & Access Management (IAM), Telecommunications and Managed Mobility Services (MMS), Analytics &
